Sign In
Buy HSCS
$2.04
-0.0350 (-1.69%)
At Close: Jun 03, 2026
HeartSciences Announces FDA 510(k) Submission for MyoVista® wavECG™ Device
08:30am, Monday, 15'th Dec 2025
Southlake, TX, Dec. 15, 2025 (GLOBE NEWSWIRE) -- HeartSciences Inc. (Nasdaq: HSCS; HSCSW) (“HeartSciences” or the “Company”), a healthcare information technology (“HIT”) company advanci
HeartSciences Announces Major Upgrade to User Features of MyoVista Insights Platform with Commercial Launch Version 1.1
08:30am, Thursday, 11'th Dec 2025
Southlake, TX, Dec. 11, 2025 (GLOBE NEWSWIRE) -- HeartSciences Inc. (Nasdaq: HSCS; HSCSW) (“HeartSciences” or the “Company”), a healthcare information technology (“HIT”) company advancin
HeartSciences (HSCS) to Release Quarterly Earnings on Monday
01:20am, Monday, 08'th Dec 2025
HeartSciences (NASDAQ: HSCS - Get Free Report) is projected to release its results before the market opens on Monday, December 15th. Analysts expect HeartSciences to post earnings of ($0.90) per share
Reviewing Hims & Hers Health (NYSE:HIMS) and HeartSciences (NASDAQ:HSCS)
02:14am, Sunday, 07'th Dec 2025
Hims and Hers Health (NYSE: HIMS - Get Free Report) and HeartSciences (NASDAQ: HSCS - Get Free Report) are both medical companies, but which is the superior business? We will compare the two companies
HeartSciences (NASDAQ:HSCS) and Bullfrog AI (NASDAQ:BFRG) Critical Analysis
02:36am, Sunday, 26'th Oct 2025
Bullfrog AI (NASDAQ: BFRG - Get Free Report) and HeartSciences (NASDAQ: HSCS - Get Free Report) are both small-cap medical companies, but which is the better stock? We will compare the two businesses
HeartSciences Inc. (HSCS) May Find a Bottom Soon, Here's Why You Should Buy the Stock Now
10:56am, Tuesday, 21'st Oct 2025
After losing some value lately, a hammer chart pattern has been formed for HeartSciences Inc. (HSCS), indicating that the stock has found support. This, combined with an upward trend in earnings estim
HeartSciences Provides Business Update and Reports First Quarter of Fiscal 2026 Financial Results
04:15pm, Thursday, 11'th Sep 2025
Southlake, TX, Sept. 11, 2025 (GLOBE NEWSWIRE) -- HeartSciences Inc. (Nasdaq: HSCS; HSCSW) ("HeartSciences" or the "Company"), an artificial intelligence (“AI”)-powered medical technology company
HeartSciences Announces Conference Participation and Investor Webinar
09:00am, Friday, 15'th Aug 2025
Virtual Events Include Investor Webinar and Presentation at Emerging Growth Conference 85 Virtual Events Include Investor Webinar and Presentation at Emerging Growth Conference 85
HeartSciences Provides Business Update and Reports Fiscal 2025 Financial Results
04:15pm, Thursday, 24'th Jul 2025
Southlake, TX, July 24, 2025 (GLOBE NEWSWIRE) -- HeartSciences Inc. (Nasdaq: HSCS; HSCSW) ("HeartSciences" or the "Company"), an artificial intelligence (“AI”)-powered medical technology company t
HeartSciences Receives FDA Breakthrough Device Designation for MyoVista Insights AI-ECG Algorithm for Detecting Aortic Stenosis
09:00am, Wednesday, 04'th Jun 2025
Southlake, TX, June 04, 2025 (GLOBE NEWSWIRE) -- HeartSciences Inc. (Nasdaq: HSCS; HSCSW) (“HeartSciences” or the “Company”), an artificial intelligence (“AI”) powered medical technology c
HeartSciences Signs First MyoVista Insights™ Platform Customer, Marking Major Commercial Milestone
09:00am, Thursday, 29'th May 2025
Southlake, TX, May 29, 2025 (GLOBE NEWSWIRE) -- HeartSciences Inc. (Nasdaq: HSCS; HSCSW) (“HeartSciences” or the “Company”), an artificial intelligence (“AI”)-powered medical technology co
HeartSciences' CEO Andrew Simpson to Present at Emerging Growth Conference 82 on Wednesday, May 21, 2025
09:00am, Tuesday, 20'th May 2025
Southlake, TX, May 20, 2025 (GLOBE NEWSWIRE) -- HeartSciences Inc . (Nasdaq:HSCS) ("HeartSciences" or the "Company"), an artificial intelligence (AI)-powered medical technology company focused on tran
HeartSciences to Host Investor Webinar and Q&A on Wednesday May 14, 2025 - Featuring CEO Andrew Simpson
09:00am, Thursday, 08'th May 2025
Southlake, TX, May 08, 2025 (GLOBE NEWSWIRE) -- HeartSciences Inc. (Nasdaq:HSCS) ("HeartSciences" or the "Company"), an artificial intelligence (AI)-powered medical technology company focused on trans
HeartSciences Adds Prominent Key Advisors to its Scientific Advisory Board
09:00am, Wednesday, 07'th May 2025
Southlake, TX, May 07, 2025 (GLOBE NEWSWIRE) -- HeartSciences Inc. (Nasdaq:HSCS) ("HeartSciences" or the "Company"), an artificial intelligence (AI)-powered medical technology company focused on tra
HeartSciences Announces Launch of MyoVista Insights™ Platform and Related Early Adopter Program
09:00am, Thursday, 01'st May 2025
Southlake, TX, May 01, 2025 (GLOBE NEWSWIRE) -- HeartSciences Inc. (Nasdaq: HSCS; HSCSW) ("HeartSciences" or the "Company"), an artificial intelligence ("AI")-powered medical technology company focuse
